CDNA Insider Trading

CareDx, Inc (CDNA) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry, with a market capitalization near $3.38B, listed on NASDAQ, employing roughly 763 people, carrying a beta of 2.38 to the broader market. CareDx, Inc. Led by John Walter Hanna Jr., public since 2014-07-17.

In the last 12 months, CareDx, Inc insiders made 0 buy transactions and 26 sale transactions.

DateNameTypeSharesPriceValue
Oct 5, 2026Novack Jeffrey AdamF-InKind997$66.23$66.0K
Oct 5, 2026Hanna John Walter JRF-InKind8,511$66.23$563.7K
Oct 5, 2026Kennedy KeithF-InKind3,018$66.23$199.9K
Oct 5, 2026Meng JessicaF-InKind2,619$66.23$173.5K
Oct 5, 2026Goldberg MichaelA-Award588$0.00$0
Sep 15, 2026Kennedy KeithF-InKind8,220$52.37$430.5K
Sep 15, 2026Meng JessicaF-InKind6,688$52.37$350.3K
Aug 6, 2026Bickerstaff GeorgeS-Sale20,000$46.28$925.7K
Aug 6, 2026COURNOYER CHRISTINES-Sale16,000$46.94$751.0K
Aug 6, 2026Novack Jeffrey AdamS-Sale2,188$46.15$101.0K

CDNA Insider Activity by Quarter

Reported Form 4 and Form 5 lines under CDNA's own SEC company ID, by transaction date, back to Q4 2024. Purchases and sales are code P / S (open market or private) in the company's shares; other lines are purchases and sales of other securities (options, warrants, preferred), awards, exercises, tax withholding, gifts and other acquisitions and dispositions. Later filings and amendments can change the current quarter. Earlier quarters are not shown: the filings read reach back to Jan 6, 2022, and a quarter counts only when every filing for it was read.

QuarterPurchasesBoughtSalesSoldOther Lines
Q4 2026 (so far)0N/A0N/A5
Q3 20260N/A9$9.4M16
Q2 20260N/A10$3.0M27
Q1 20260N/A4$717.3K23
Q4 20250N/A3$181.5K4
Q3 20250N/A2$220.2K9
Q2 20250N/A10$2.3M27
Q1 20250N/A2$448.9K10
Q4 20240N/A7$324.7K10

CDNA Institutional Ownership (13F)

As of Jun 30, 2026 (Q2 2026), 227 institutions reported holding 53,395,256 CDNA shares, valued at $1.52B as reported, 103.2% of its market cap (market cap of Jun 26, 2026). That is +36 institutions from the quarter before. Among managers whose reports for both quarters are comparable, 51 opened a position, 12 closed one, 77 added and 68 trimmed.

Top Holders, Q2 2026

ManagerSharesValueChange
BlackRock, Inc.4,814,709$137.2M+292,613
STATE STREET CORP2,468,858$70.4M-291,527
VANGUARD CAPITAL MANAGEMENT LLC2,197,475$62.6M+37,018
DEERFIELD MANAGEMENT COMPANY, L.P.1,997,618$56.9M-193,382
ARK Investment Management LLC1,953,531$55.7M-274,025
Boston Partners1,937,601$55.2M+54,067
BAMCO INC /NY/1,937,326$55.2M-1,399,083
GAGNON SECURITIES LLC1,770,735$50.5M+8,861
Chevy Chase Trust Holdings, LLC1,437,416$41.0M-66,659
GEODE CAPITAL MANAGEMENT, LLC1,328,037$37.9M+73,923

By Quarter

QuarterInstitutionsSharesValue
Q2 202622753,395,256$1.52B
Q1 202619152,549,160$912.3M
Q4 202520052,179,231$983.1M
Q3 202518753,635,628$779.9M
Q2 202519554,277,531$1.05B
Q1 202521856,048,838$995.3M
Q4 202421053,098,713$1.14B
Q3 202421551,661,105$1.61B
Q2 202415454,145,057$840.7M

From the SEC's Form 13F data sets: investment managers with $100 million or more in Section 13(f) securities report their holdings each quarter, up to 45 days after it ends; a restated filing replaces the original, and values are as the managers reported them (a position whose price runs about 1,000 times below other managers', from a manager whose positions mostly do, is read as reported in thousands of dollars). The same shares can be reported by more than one manager, so totals can count some twice.

ETFs Holding CDNA

FundWeight of CDNAShares (as reported)Value (as reported)Source updated
ARKG ARK Genomic Revolution ETF4.30%1,437,923$90.6MOct 8, 2026
XBI State Street SPDR S&P Biotech ETF0.85%1,339,021$85.6MOct 8, 2026
IWM iShares Russell 2000 ETF0.11%1,348,422$85.0MOct 8, 2026
IWO iShares Russell 2000 Growth ETF0.22%479,819$30.2MOct 8, 2026
IBB iShares Biotechnology ETF0.22%357,933$22.6MOct 8, 2026
SCHA Schwab U.S. Small-Cap ETF0.08%272,327$17.1MOct 8, 2026
DFAC Dimensional - US Core Equity 2 ETF0.02%221,690$14.1MOct 8, 2026
FESM Fidelity Enhanced Small Cap ETF0.20%210,357$13.3MOct 8, 2026
IWC iShares Micro-Cap ETF0.77%161,384$10.2MOct 8, 2026
FYC First Trust Small Cap Growth AlphaDEX Fund0.62%131,581$8.3MOct 8, 2026
AVSC Avantis U.S. Small Cap Equity ETF0.22%104,338$6.6MOct 8, 2026
PTH Invesco Dorsey Wright Healthcare Momentum ETF2.05%91,184$5.7MOct 8, 2026
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.50%82,814$5.3MOct 8, 2026
PSC Principal U.S. Small-Cap Multi-Factor ETF0.19%82,514$5.2MOct 8, 2026
SEIS SEI Exchange Traded Funds - SEI Select Small Cap ETF0.86%82,035$5.2MOct 8, 2026

From each fund's latest holdings file on record that shows CDNA's listed security itself. A file counts when its line count is consistent with the fund's reported holdings count (at most twice it plus 10, or at most 1,000 lines for a reported count of exactly 10, which the data source gives many funds as a cap), read with that file or inherited from the fund's last classified file (within 20% of its line count, read within 60 days). Funds whose line for the company could not be confirmed as CDNA's listed security, or that hold it through underlying funds (look-through), are not listed. Only long positions count: a fund is left out when any of its lines for CDNA reports a negative weight, share count or value, or none of them above zero (a short position, or figures that disagree). Shares, value and weight are as reported in each fund's file, dated by the data source's last update of that file (not the date of the positions); the weight is CDNA's share of that fund.

CDNA Congress Trades

Members of Congress and their households disclosed 1 transaction in CDNA on file (0 purchases, 1 sales) by 1 member, the latest trade on Mar 6, 2023.

MemberChamberTypeAmountTradedDisclosed
Daniel S. Goldman (D-NY-10)HouseSale (Full)$1,001 - $15,000Mar 6, 2023Apr 17, 2023

From the periodic transaction reports members of the Senate and the House file under the STOCK Act, within 45 days of a trade (some file later); amounts are the ranges the reports give (a few give an exact amount), and a transaction a later report lists again is counted once. On file: House reports disclosed from Apr 10, 2023 through Oct 13, 2026; Senate reports disclosed from Jan 30, 2014 through Oct 7, 2026. The party is the member's on the trade date. A trade is listed under the company that traded under its ticker on the trade date (dated from Feb 1, 2021, unless the filing describes another company of ours; before that, only when the filing's description of the security is the company's name).

How to Read CDNA Insider Activity

Net insider sentiment skews to the sell side over the trailing twelve months: 26 sales versus 0 buys. Insider sales carry less informational weight than buys because they are often driven by liquidity, tax planning, or pre-scheduled Rule 10b5-1 trading plans rather than negative information. The transaction type alone does not say whether a sale was made on the open market or privately, or under a 10b5-1 plan; the filing's plan checkbox and footnotes do. The transaction table above includes the filer's reporting name, transaction type, share count, per-share price, and total dollar value where computable. For options traders, insider activity is one input to event-driven sizing alongside earnings calendar, analyst-rating cluster moves, and the implied-vol surface. Form 4 filings (the dominant Section 16 reporting form) must be submitted within two business days of the transaction; clusters of buys across multiple insiders within a short window are the strongest informational pattern. SEC EDGAR carries the underlying source filings for verification and additional historical depth.

Learn how insider trading is reported and how to read the data →

Frequently asked CDNA insider trading questions

How active are CDNA insiders right now?
Over the trailing twelve months, CareDx, Inc (CDNA) insiders made 0 buy transactions and 26 sale transactions. Net insider sentiment over the trailing twelve months tilts to the sell side (26 sales vs 0 buys). The transaction list above shows the most recent filings; each entry includes the insider's name, transaction type, share count, and per-share price.
What counts as an insider transaction?
Section 16 of the Securities Exchange Act requires officers, directors, and 10% beneficial-owner shareholders to disclose changes in their holdings via Form 3 (initial statement), Form 4 (subsequent transactions, filed within two business days), and Form 5 (annual catch-up). Insider transactions cover open-market purchases and sales, exercise of stock options, gifts, and grants. The "transaction type" field on each row distinguishes these subcategories.
Are CDNA insider buys a bullish signal?
Insider purchases (Type P, made on the open market or privately; the code covers both) carry more informational weight than insider sales: an insider must commit personal capital, and the SEC scrutinizes purchases under Rule 10b5-1 for material non-public information. Sales, by contrast, are often driven by liquidity, tax planning, or pre-scheduled 10b5-1 trading plans rather than negative information. Cluster buying (multiple insiders buying within a short window) is a stronger signal than isolated buys.
How do CDNA insider transactions affect options pricing?
Insider transaction data does not directly drive implied volatility, but Form 4 disclosures can move single-name IV if the size or timing is unusual (e.g. a large CEO buy ahead of an earnings window). Options markets price the marginal informational content; routine transactions under pre-scheduled plans are typically ignored. For event-driven options sizing, pair the insider transaction history with the upcoming earnings calendar.